[1] 倪志宇, 王永祥, 金玉怀, 金世香. 柯萨奇病毒B组3型VP1基因真核表达重组质粒的构建及免疫效果 [J]. 河北医科大学学报 2002.doi:10.3969/j.issn.1007-3205.2002.03.002
[2] 王灵枢, 刘晶星, 朱莉, 陆德源. 柯萨奇B3病毒结构和非结构蛋白DNA 疫苗诱导小鼠产生免疫应答的研究 [J]. 中华微生物学和免疫学杂志 2001.doi:10.3760/j:issn:0254-5101.2001.01.013
[3] YAMASHITA U, KURODA E. Regulation of macrophage-derived chemokine (MDC, CCL22) production [J]. Critical Reviews in Immunology 2002, 22(02).
[4] BIRAGYN A, BELYAKOV I M, CHOW Y H. DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses [J]. Blood 2002, 100(04).
[5] 谷志远. 现代医学分子生物学 [M]. 北京:人民军医出版社 1998.
[6] 李影林. 中华医学检验全书 [M]. 北京:人民卫生出版社 1997.
[7] Schaniel C ii.ch, Pardali E, Sallusto F, Speletas M, Ruedl C, Shimizu T, Seidl T, Andersson J, Melchers F, Rolink AG, Sideras P. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. [J]. The Journal of Experimental Medicine 1998, 3(3).
[8] Kikuchi T, Crystal RG. Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity. [J]. The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation 2001, 6(6). |
